Novo Nordisk Stock Plummets 7.63% in High-Volume Trading Day Ranking 1st in Volume

On April 17, 2025, Novo Nordisk (NVO) experienced a significant drop in its stock price, closing at $58.19, marking a 7.63% decrease. This decline follows a three-day losing streak, with the stock shedding a total of 12.08% over the past three days. The trading volume for the day was 20,227,184 shares, which is 252.4% higher than the average daily volume of 8,013,333 shares.

Novo Nordisk's stock price has been under pressure, with the current price 60.72% below its 52-week high of $148.15 and only 1.59% above its 52-week low of $57.28. The intraday low for the stock was $57.28, before it recovered slightly to close at $58.19.

Analysts have provided varying price targets for Novo Nordisk. Based on the one-year price targets offered by nine analysts, the average target price for the stock is $112.19, with a high estimate of $166.46 and a low estimate of $67.63. This average target implies an upside of 92.80% from the current price of $58.19.

The consensus recommendation from 15 brokerage firms indicates an "Outperform" status for Novo Nordisk, with an average brokerage recommendation of 2.3 on a scale where 1 signifies a Strong Buy and 5 denotes a Sell. Additionally, GuruFocus estimates the GF Value for Novo Nordisk in one year to be $158.43, suggesting an upside of 172.26% from the current price.